CD8A and neoplasm: Recent research demonstrated that gut-derived Lactobacillus reuteri migrates to the tumor site and produces I3A in an AhR-dependent manner, thereby inducing the cytotoxic activity of CD8+ T cells and enhancing the efficacy of anti-PD-L1 therapy (Bender et al., 2023).